Maria Lola Evia-Viscarra
Overview
Explore the profile of Maria Lola Evia-Viscarra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oral glucose tolerance test curve shape in Mexican children and adolescents with and without obesity
Evia-Viscarra M, Jacobo-Tovar E, Meneses-Rojas L, Guardado-Mendoza R
J Pediatr Endocrinol Metab
. 2024 Oct;
37(10):850-858.
PMID: 39382514
Objectives: Mexican children with obesity are at a higher risk of developing type 2 diabetes mellitus (T2DM). The aim of the study was to compare oral glucose tolerance test (OGTT)...
2.
Martinez-Lopez Y, Neri-Rosario D, Esquivel-Hernandez D, Padron-Manrique C, Vazquez-Jimenez A, Sanchez-Castaneda J, et al.
Sci Rep
. 2024 Sep;
14(1):21124.
PMID: 39256606
No abstract available.
3.
Martinez-Lopez Y, Neri-Rosario D, Esquivel-Hernandez D, Padron-Manrique C, Vazquez-Jimenez A, Sanchez-Castaneda J, et al.
Sci Rep
. 2024 Apr;
14(1):9678.
PMID: 38678119
Lifestyle modifications, metformin, and linagliptin reduce the incidence of type 2 diabetes (T2D) in people with prediabetes. The gut microbiota (GM) may enhance such interventions' efficacy. We determined the effect...
4.
Alvarez-Canales M, Salazar-Lopez S, Farfan-Vazquez D, Martinez-Lopez Y, Gonzalez-Mena J, Jimenez-Ceja L, et al.
Sci Rep
. 2021 Apr;
11(1):8750.
PMID: 33888772
The goal of the study was to evaluate the effect of adding linagliptin to metformin and lifestyle on glucose levels and pancreatic β-cell function in patients with persistent impaired glucose...
5.
Guardado-Mendoza R, Salazar-Lopez S, Alvarez-Canales M, Farfan-Vazquez D, Martinez-Lopez Y, Jimenez-Ceja L, et al.
Metabolism
. 2019 Dec;
104:154054.
PMID: 31887309
Background: Prediabetes is a highly prevalent health problem with a high risk of complications and progression to type 2 diabetes (T2D). The goals of this study were to evaluate the...
6.
Evia-Viscarra M, Guardado-Mendoza R
J Pediatr Endocrinol Metab
. 2019 Dec;
33(2):215-222.
PMID: 31834862
Background There is no consensus on the definition of metabolically healthy obesity (MHO) and the diagnostic criteria in children. Objectives To estimate the prevalence of MHO and compare clinical and...
7.
Guardado-Mendoza R, Cazares-Sanchez D, Evia-Viscarra M, Jimenez-Ceja L, Duran-Perez E, Aguilar-Garcia A
Diabetes Res Clin Pract
. 2019 Sep;
156:107864.
PMID: 31539565
Aims: Post-renal-transplanted patients frequently present hyperglycemia immediately after the procedure. The goal of this work was to evaluate the effect of linagliptin + insulin in post-renal-transplanted patients with hyperglycemia. Methods:...
8.
Evia-Viscarra M, Guardado-Mendoza R, Rodea-Montero E
PLoS One
. 2016 Dec;
11(12):e0168377.
PMID: 27992493
Background: Current classification of diabetes mellitus (DM) is based on etiology and includes type 1 (T1DM), type 2 (T2DM), gestational, and other. Clinical and pathophysiological characteristics of T1DM and T2DM...
9.
Rodea-Montero E, Evia-Viscarra M, Apolinar-Jimenez E
Int J Endocrinol
. 2015 Jan;
2014:195407.
PMID: 25574166
Objective. To identify the degree of association between anthropometric indices and components of metabolic syndrome (MS) and to determine optimal cut-off points of these indices for predicting MS in obese...
10.
Evia-Viscarra M, Rodea-Montero E, Apolinar-Jimenez E, Quintana-Vargas S
Endocr Connect
. 2013 Oct;
2(4):208-15.
PMID: 24145615
The aim of this study was to estimate the prevalence of metabolic syndrome (MS) and its components in obese Mexican adolescents and to compare the clinical, anthropometric, and biochemical characteristics...